Pulmonology Articles

Pulmonology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Shiroiwa T et al. - Although the threshold of cost effectiveness of medical interventions is thought to be £20 000-£30 000 in the UK, and $50 000-$100 000 in the US, it is well known that these values are unjustified, due to lack of explicit scientific evidence. The authors suggest new classification of cost-effectiveness plane and methodology for decision making.

Related Articles

Complementing the net benefit approach: A new framework for Bayesian cost-effectiveness analysis
International Journal of Technology Assessment in Health Care, 11/05/09    Relevance Score: 69%

Much Cheaper, Almost as Good: Decrementally Cost-Effective Medical Innovation
Annals of Internal Medicine, 11/04/09    Relevance Score: 69%

Economic evaluation of arthritis self management in primary care
British Medical Journal, 10/08/09    Relevance Score: 69%

Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions: A Comparison of Britain, Australia, and Canada
JAMA, 10/07/09    Relevance Score: 68%

Cost-effectiveness analysis of trastuzumab (herceptin) in HER2-overexpressed metastatic breast cancer
American Journal of Clinical Oncology, 10/06/09    Relevance Score: 68%

Today in Economics of Medicine...keeping you current

California to receive federal matching funds for electronic health record incentives program
Centers for Medicare & Medicaid Services Press, 12/18/09

Understanding the Economic Impact of a Pandemic
AMN Healthcare, 12/17/09

HHS Gets Advice on Incentive Definitions
HealthDataManagement, 12/16/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address